Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

27.78  +1.66 (+6.36%)

After market: 27.78 0 (0%)

Fundamental Rating

3

Overall XMTR gets a fundamental rating of 3 out of 10. We evaluated XMTR against 49 industry peers in the Trading Companies & Distributors industry. XMTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XMTR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XMTR had negative earnings in the past year.
In the past year XMTR has reported a negative cash flow from operations.
XMTR had negative earnings in each of the past 5 years.
XMTR had a negative operating cash flow in each of the past 5 years.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

XMTR's Return On Assets of -7.41% is on the low side compared to the rest of the industry. XMTR is outperformed by 93.88% of its industry peers.
XMTR has a worse Return On Equity (-16.03%) than 91.84% of its industry peers.
Industry RankSector Rank
ROA -7.41%
ROE -16.03%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

XMTR's Gross Margin of 39.53% is fine compared to the rest of the industry. XMTR outperforms 67.35% of its industry peers.
In the last couple of years the Gross Margin of XMTR has grown nicely.
XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XMTR has been increased compared to 1 year ago.
The number of shares outstanding for XMTR has been increased compared to 5 years ago.
Compared to 1 year ago, XMTR has a worse debt to assets ratio.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

XMTR has an Altman-Z score of 2.52. This is not the best score and indicates that XMTR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.52, XMTR is in line with its industry, outperforming 44.90% of the companies in the same industry.
A Debt/Equity ratio of 0.90 indicates that XMTR is somewhat dependend on debt financing.
The Debt to Equity ratio of XMTR (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACCN/A
WACC8.92%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 4.38 indicates that XMTR has no problem at all paying its short term obligations.
The Current ratio of XMTR (4.38) is better than 87.76% of its industry peers.
XMTR has a Quick Ratio of 4.33. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
XMTR has a better Quick ratio (4.33) than 97.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 4.33
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

XMTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.50%, which is quite impressive.
XMTR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.74%.
XMTR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.73% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)17.74%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%15.92%

3.2 Future

The Earnings Per Share is expected to grow by 188.58% on average over the next years. This is a very strong growth
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 17.24% on average per year.
EPS Next Y675.73%
EPS Next 2Y285.68%
EPS Next 3Y188.58%
EPS Next 5YN/A
Revenue Next Year18.77%
Revenue Next 2Y18.08%
Revenue Next 3Y17.4%
Revenue Next 5Y17.24%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XMTR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 96.50, which means the current valuation is very expensive for XMTR.
75.51% of the companies in the same industry are cheaper than XMTR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. XMTR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 96.5
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

XMTR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 188.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y285.68%
EPS Next 3Y188.58%

More info and screens

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (5/2/2025, 8:00:02 PM)

After market: 27.78 0 (0%)

27.78

+1.66 (+6.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners95.19%
Inst Owner Change-0.16%
Ins Owners6.23%
Ins Owner Change11.19%
Market Cap1.41B
Analysts80
Price Target33.55 (20.77%)
Short Float %9.88%
Short Ratio6.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)142.65%
Min EPS beat(2)100.56%
Max EPS beat(2)184.74%
EPS beat(4)4
Avg EPS beat(4)97.38%
Min EPS beat(4)12.07%
Max EPS beat(4)184.74%
EPS beat(8)8
Avg EPS beat(8)62.96%
EPS beat(12)11
Avg EPS beat(12)49.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.36%
PT rev (3m)-6.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-115.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 96.5
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B 4.48
P/tB 71.73
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.29
Fwd EY1.04%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS10.76
BVpS6.2
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.41%
ROE -16.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.53%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.08%
Cap/Sales 3.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.38
Quick Ratio 4.33
Altman-Z 2.52
F-Score5
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y675.73%
EPS Next 2Y285.68%
EPS Next 3Y188.58%
EPS Next 5YN/A
Revenue 1Y (TTM)17.74%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%15.92%
Revenue Next Year18.77%
Revenue Next 2Y18.08%
Revenue Next 3Y17.4%
Revenue Next 5Y17.24%
EBIT growth 1Y23.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.35%
EBIT Next 3Y86.72%
EBIT Next 5Y64.67%
FCF growth 1Y30.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.51%
OCF growth 3YN/A
OCF growth 5YN/A